Skip to content

Drug interactions

Pomalidomide + Ranolazine

Severity: Minor

Pomalidomide and Ranolazine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ranolazine inhibits P-glycoprotein and could raise pomalidomide exposure, since pomalidomide is a P-gp substrate. The clinical impact is expected to be small and has not been well characterized.

What this interaction means in plain words

Pomalidomide and Ranolazine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Pomalidomide belongs to Miscellaneous; Ranolazine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Possible P-glycoprotein inhibition by ranolazine reducing pomalidomide efflux.

What to do

No dose change is usually needed; monitor for pomalidomide adverse effects such as neutropenia.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pomalidomide and Ranolazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Pomalidomide with Ranolazine?

MediHelp rates the interaction as minor. Pomalidomide and Ranolazine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ranolazine inhibits P-glycoprotein and could raise pomalidomide exposure, since pomalidomide is a P-gp substrate. The clinical impact is expected to be small and has not been well characterized.

How serious is the interaction between Pomalidomide and Ranolazine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed; monitor for pomalidomide adverse effects such as neutropenia.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in